Search research articles
Contact Us
Filters
Showing results (171-180 of 188) with videos related to
Page
of 19
Sort By:
BMC Health Services Research
|
May 17, 2022
Influences of post-implementation factors on the sustainability, sustainment, and intra-organizational spread of complex interventions
Yuting Song, Lauren MacEachern, Malcolm B Doupe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 12, 2018
Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study
A R Hansen, C Massard, P A Ott, et al.
The Lancet. Oncology
|
October 3, 2017
First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study
Arjun V Balar, Daniel Castellano, Peter H O'Donnell, et al.
Cancer Chemotherapy and Pharmacology
|
May 10, 2023
Advanced statistics identification of participant and treatment predictors associated with severe adverse effects induced by fluoropyrimidine-based chemotherapy
Samantha K Korver, Joanne M Bowen, Rachel J Gibson, et al.
The British Journal of Dermatology
|
May 10, 2002
Anti-E-selectin is ineffective in the treatment of psoriasis: a randomized trial
M Bhushan, T O Bleiker, A E Ballsdon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 29, 2016
Reaffirming and Clarifying the American Society of Clinical Oncology's Policy Statement on the Critical Role of Phase I Trials in Cancer Research and Treatment
Jeffrey S Weber, Laura A Levit, Peter C Adamson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 17, 2014
American Society of Clinical Oncology policy statement update: the critical role of phase I trials in cancer research and treatment
Jeffrey S Weber, Laura A Levit, Peter C Adamson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2023
First-Line Pembrolizumab + Chemotherapy Versus Placebo + Chemotherapy for Persistent, Recurrent, or Metastatic Cervical Cancer: Final Overall Survival Results of KEYNOTE-826
Bradley J Monk, Nicoletta Colombo, Krishnansu S Tewari, et al.
Implementation Science : IS
|
February 5, 2017
Pathways for best practice diffusion: the structure of informal relationships in Canada's long-term care sector
James W Dearing, Amanda M Beacom, Stephanie A Chamberlain, et al.
The New England Journal of Medicine
|
September 17, 2021
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer
Nicoletta Colombo, Coraline Dubot, Domenica Lorusso, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 188) with videos related to
Sort By:
Page
of 19
BMC Health Services Research
|
May 17, 2022
Influences of post-implementation factors on the sustainability, sustainment, and intra-organizational spread of complex interventions
Yuting Song, Lauren MacEachern, Malcolm B Doupe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 12, 2018
Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study
A R Hansen, C Massard, P A Ott, et al.
The Lancet. Oncology
|
October 3, 2017
First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study
Arjun V Balar, Daniel Castellano, Peter H O'Donnell, et al.
Cancer Chemotherapy and Pharmacology
|
May 10, 2023
Advanced statistics identification of participant and treatment predictors associated with severe adverse effects induced by fluoropyrimidine-based chemotherapy
Samantha K Korver, Joanne M Bowen, Rachel J Gibson, et al.
The British Journal of Dermatology
|
May 10, 2002
Anti-E-selectin is ineffective in the treatment of psoriasis: a randomized trial
M Bhushan, T O Bleiker, A E Ballsdon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 29, 2016
Reaffirming and Clarifying the American Society of Clinical Oncology's Policy Statement on the Critical Role of Phase I Trials in Cancer Research and Treatment
Jeffrey S Weber, Laura A Levit, Peter C Adamson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 17, 2014
American Society of Clinical Oncology policy statement update: the critical role of phase I trials in cancer research and treatment
Jeffrey S Weber, Laura A Levit, Peter C Adamson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2023
First-Line Pembrolizumab + Chemotherapy Versus Placebo + Chemotherapy for Persistent, Recurrent, or Metastatic Cervical Cancer: Final Overall Survival Results of KEYNOTE-826
Bradley J Monk, Nicoletta Colombo, Krishnansu S Tewari, et al.
Implementation Science : IS
|
February 5, 2017
Pathways for best practice diffusion: the structure of informal relationships in Canada's long-term care sector
James W Dearing, Amanda M Beacom, Stephanie A Chamberlain, et al.
The New England Journal of Medicine
|
September 17, 2021
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer
Nicoletta Colombo, Coraline Dubot, Domenica Lorusso, et al.
Page
of 19